| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
18,391,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Phoenix Biotech Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
7,440,850 |
7,440,850 |
| Total Sell Value |
$0 |
$0 |
$763,908 |
$763,908 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
5 |
5 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Atwood Brian G |
Director |
– • – |
2025-03-31 |
4 |
OE |
$0.00 |
$29 |
I/I |
294,460 |
490,534 |
|
- |
|
| Yeung Gary Kahing |
10% Owner |
– – • |
2024-12-10 |
4 |
S |
$0.09 |
$141,385 |
I/I |
(1,570,947) |
18,962,419 |
|
- |
|
| Yeung Gary Kahing |
10% Owner |
– – • |
2024-12-09 |
4 |
S |
$0.11 |
$93,560 |
I/I |
(850,543) |
20,533,366 |
|
- |
|
| Yeung Gary Kahing |
10% Owner |
– – • |
2024-12-06 |
4 |
S |
$0.12 |
$148,425 |
I/I |
(1,236,874) |
21,383,909 |
|
- |
|
| Patel Shami |
Director |
– • – |
2024-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,120,254 |
|
- |
|
| Yeung Gary Kahing |
10% Owner |
– – • |
2024-10-10 |
4 |
S |
$0.10 |
$325,000 |
I/I |
(3,250,000) |
22,620,783 |
|
- |
|
| Yeung Gary Kahing |
10% Owner |
– – • |
2024-09-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,870,783 |
|
- |
|
| Sloan Stuart M |
10% Owner |
– – • |
2024-09-25 |
4 |
S |
$0.10 |
$55,538 |
I/I |
(532,486) |
21,067,956 |
|
- |
|
| Ehrlich Christopher B |
Interim Chairman and CEO |
• • – |
2024-09-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,312,983 |
5,791,808 |
|
- |
|
| Laporte Kathleen |
Director |
– • – |
2024-09-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
965,997 |
965,997 |
|
- |
|
| Atwood Brian G |
Director |
– • – |
2024-09-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
19,358,578 |
19,607,313 |
|
- |
|
| Sloan Stuart M |
10% Owner |
– – • |
2024-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,600,442 |
|
- |
|
| Rapaport Robyn |
Director |
– • – |
2024-02-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| Corey Daniel |
Chief Technical OfficerOfficer |
• • – |
2024-02-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
683,015 |
|
- |
|
| Geffken Daniel E |
Chief Financial Officer |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,002 |
10,002 |
|
- |
|
| Kosacz Barbara |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
| Ehrlich Christopher B |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,600 |
3,600 |
|
- |
|
| Ehrlich Christopher B |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
478,825 |
478,825 |
|
- |
|
| Ehrlich Christopher B |
Director |
– • – |
2024-02-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,296,246) |
1,000,000 |
|
- |
|
| Phoenix Biotech Sponsor, Llc |
10% Owner |
– – • |
2024-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,296,246) |
1,000,000 |
|
- |
|
| Atwood Brian G |
Chief Executive Officer |
• • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
248,735 |
248,735 |
|
- |
|
| Atwood Brian G |
Chief Executive Officer |
• • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
|
- |
|
| Fisher Douglas |
President |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
43,300 |
43,300 |
|
- |
|
| Loewy Caroline M |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
| Laporte Kathleen |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
30 Records found
|
|
Page 1 of 2 |
|
|
